Trovagene Inc TROV Financial and Strategic SWOT Analysis Review [Report Updated: 25042018] Prices from USD $125

04:47 EDT 10 Aug 2018 | BioPortfolio Reports

Trovagene Inc TROV Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Trovagene Inc Trovagene is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests that provide important clinical information about mutations associated with common solid tumor cancers such as colorectal, melanoma, pancreas and lung cancer. These tests are used by physicians, third party clinical laboratories and pharmaceutical companies. Trovagene uses its proprietary Precision Cancer Monitoring PCM technology to detect and monitor circulating tumor DNA ctDNA in urine and blood for the detection and quantitation of oncogene mutations and improvement in cancer care. Trovagene is headquartered in San Diego, California, the US.

Trovagene Inc Key Recent Developments

Feb 26,2018: Trovagene Announces Fourth Quarter and FullYear 2017 Results

Jan 03,2018: Trovagene to Present at the Biotech Showcase Annual Conference

Dec 12,2017: Trovagene Announces the Launch of NextCollect Urine Collection and DNA Preservation Kit to Research Laboratories and Pharmaceutical Customers

Nov 09,2017: Trovagene Announces Third Quarter 2017 Company Highlights and Financial Results

Sep 20,2017: Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Trovagene Inc TROV Financial and Strategic SWOT Analysis Review [Report Updated: 25042018] Prices from USD $125


More From BioPortfolio on "Trovagene Inc TROV Financial and Strategic SWOT Analysis Review [Report Updated: 25042018] Prices from USD $125"

Quick Search


Relevant Topics

Molecular diagnostics
Molecular diagnostics is a technique used to analyse biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. The tec...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...